Today, Judge Gregory Sleet of the U.S. District Court of Delaware orally dismissed Genentech’s lawsuit against Amgen alleging violations of the BPCIA. Judge Sleet did not issue a written opinion, but his order states that...more
3/2/2017
/ Amgen ,
BPCIA ,
Commercial Marketing ,
Discovery Disputes ,
Dismissals ,
Exclusive Remedy ,
Genentech ,
Generic Drugs ,
Patent Infringement ,
Patents ,
Pharmaceutical Patents ,
Written Notice